Showing results (141-150 of 522) with videos related to
Sort By:
Pageof 53
Cancer Treatment Reviews|June 9, 2018
Non-small cell lung cancer brain metastases and the immune system: From brain metastases development to treatmentElie El Rassy, Angela Botticella, Joseph Kattan, et al.Cancer Treatment Reviews|April 26, 2022
The use of immunotherapy in older patients with advanced non-small cell lung cancerMarco Tagliamento, Maxime Frelaut, Capucine Baldini, et al.ERJ Open Research|April 28, 2020
A microsimulation model to assess the economic impact of immunotherapy in non-small cell lung cancerClémence Legoupil, Didier Debieuvre, Aurelien Marabelle, et al.Nature Reviews. Clinical Oncology|July 9, 2020
Immunotherapy discontinuation - how, and when? Data from melanoma as a paradigmCaroline Robert, Aurelien Marabelle, Hugo Herrscher, et al.Clinical Lung Cancer|February 25, 2016
The Evolving Role of Nivolumab in Non-Small-Cell Lung Cancer for Second-Line Treatment: A New Cornerstone for Our Treatment Algorithms. Results From an International Experts Panel Meeting of the Italian Association of Thoracic OncologyCesare Gridelli, Benjamin Besse, Julie Renee Brahmer, et al.Cancers|August 29, 2024
Early-Stage Non-Small Cell Lung Cancer: New Challenges with Immune Checkpoint Blockers and Targeted TherapiesPernelle Lavaud, Martina Bortolot, Lodovica Zullo, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 5, 2020
Circulating T-cell Immunosenescence in Patients with Advanced Non-small Cell Lung Cancer Treated with Single-agent PD-1/PD-L1 Inhibitors or Platinum-based ChemotherapyRoberto Ferrara, Marie Naigeon, Edouard Auclin, et al.Critical Reviews in Oncology/Hematology|August 2, 2022
Tumor infiltrating lymphocytes (TILs) as a predictive biomarker of response to checkpoint blockers in solid tumors: A systematic reviewDaniele Presti, Filippo Gustavo Dall'Olio, Benjamin Besse, et al.Journal of Immunology (Baltimore, Md. : 1950)|July 23, 2014
Dendritic cell-derived exosomes as immunotherapies in the fight against cancerJonathan M Pitt, Mélinda Charrier, Sophie Viaud, et al.Nature Reviews. Clinical Oncology|October 27, 2018
Hyperprogressive disease: recognizing a novel pattern to improve patient managementStéphane Champiat, Roberto Ferrara, Christophe Massard, et al.Pageof 53